ABOUT JASMIN
A strategic mind
A patient-centred
purpose
Market Access & HEOR Strategist.
Lawyer by training. Published author.
For 14 years, I have worked at the intersection of evidence, strategy and patient access across Pharma and MedTech — from global HEOR at Novo Nordisk to international market development at Coloplast.
My work has spanned Spain, the US, Canada, Poland, Brazil and South Africa. Each market has reinforced the same lesson: evidence alone does not create access. Context, judgement and the realities of reimbursement matter.
THE EXPERIENCE BEHIND MY PERSPECTIVE
Making evidence
matter in practice
Between 2022 and 2026, my work in Spain focused on a strategy to open pathways for new MedTech categories within a rigid reimbursement environment. My priority was unmet patient need: getting beyond formal eligibility to the practical decisions that make access possible.
That experience shapes my writing on HEOR, value recognition, societal impact and AI. I ask how evidence can become decision-relevant — and where human judgement must remain central.
I hold a Cand.jur. from the University of Copenhagen and an HD2 in International Business from Copenhagen Business School. I am a former Board Member of the Coloplast Access to Healthcare Foundation.
SELECTED EXPERIENCE
Where the perspective
comes from
International Market Access Manager
Coloplast A/S
Project lead and health economist driving global market development across subsidiaries — Spain, the US, Canada, Poland, Brazil and South Africa. Spain specialist: product and population expansion alongside a top-down strategy to reopen a reimbursement system closed to new MedTech categories since 2007. Steering Committee facilitation, contract and vendor management. Managing Assistant and Board Member of the Coloplast Access to Healthcare Foundation.
Global HEOR Manager
Novo Nordisk A/S
Global HEOR strategy and partnerships across regions to enable evidence-based product launches. Project lead for budget impact models, vendor collaborations and contracting, with end-to-end project governance across global stakeholders.
Cand.jur. and HD2
University of Copenhagen · Copenhagen Business School
A legal foundation applied to health economics, reimbursement and the decisions that follow from them.
Published author
HEOR, value recognition and patient access
Articles on what evidence can and cannot do inside a reimbursement system — and what AI changes, and does not change, in HEOR.
LET’S ASK BETTER QUESTIONS